🇺🇸 FDA
Patent

US 6287759

Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

expired A61KA61K38/00A61K39/00

Quick answer

US patent 6287759 (Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Sep 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61K39/00, A61P, A61P1/16